Leonor Mateus Ferreira is an emerging journalist with a Batchelor's degree in Communication and post-graduate degree in Multiplatform Journalism. She is particularly interested in politics and current affairs, and is currently studying for a masters degree in economics and public policies.
Roche has been invited to participate in the European League Against Rheumatism Annual Congress (EULAR 2015) and present its latest data regarding treatments ... Read more
In order to understand the role of inflammation in both rheumatoid arthritis and heart failure, an international team of medical researchers is ... Read more
A new technology based on nuclear medicine has been developed and presented by the NCBJ POLATOM Radioisotope Centre located in Warsaw, Poland to be ... Read more
Emerging generic pharmaceutical company, ANI Pharmaceuticals, Inc. is going to launch a new drug for the management of the symptoms and signs of ... Read more
Biotechnology company, Neovacs recently added new members to its Scientific Advisory Board (SAB), in order to assist the company in their mission to provide ... Read more
Enbrel (etanercept) biosimilar candidate, SB4, developed by Samsung Bioepis Co., Ltd. for patients with moderate-to-severe rheumatoid arthritis, recently received validation and has been ... Read more
Immune Therapeutics, Inc. has signed an agreement with KRS Global Biotechnology, Inc., to collaborate on compounding, packaging and distributing the drug naltrexone, which ... Read more
The market for the treatment of rheumatoid arthritis (RA) will continue to experience a steady growth internationally, from a $15.6 billion value ... Read more
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more